Author： Vigna Ernesto Recchia Anna Grazia Madeo Antonio Gentile Massimo Bossio Sabrina Mazzone Carla Lucia Eugenio Morabito Lucio Gigliotti Vincenzo Stefano Laura De Caruso Nadia Servillo Pasquale Franzese Stefania Fimognari Filippo Bisconte Maria Grazia Gentile Carlo Morabito Fortunato
Publisher： Informa Healthcare
ISSN： 1354-3784
Source： Expert Opinion on Investigational Drugs, Vol.20, Iss.4, 2011-04, pp. : 465-493
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Immunosuppressive Therapy for Myelodysplastic Syndromes
Current Pharmaceutical Design, Vol. 18, Iss. 22, 2012-07 ,pp. :
Access to resources
Recommend
Epigenetic Treatment of Myelodysplastic Syndromes and Acute Myeloid Leukemias
Current Medicinal Chemistry, Vol. 15, Iss. 13, 2008-06 ,pp. :
Genetic and Epigenetic Drug Targets in Myelodysplastic Syndromes
Current Pharmaceutical Design, Vol. 23, Iss. 1, 2017-02 ,pp. :
Tipifarnib effective oral therapy for myelodysplastic syndromes
Inpharma, Vol. 1, Iss. 1477, 2005-01 ,pp. :